Interim Management Statement

Montanaro UK Smaller Companies Investment Trust PLC Interim Management Statement - 3 months to 31 December 2009 Investment Objective MUSCIT's investment objective is capital appreciation (rather than income) achieved by investing in small quoted companies listed on the London Stock Exchange or traded on the Alternative Investment Market ("AIM") and to achieve relative outperformance of its benchmark, the FTSE "SmallCap" (excluding investment companies) Index ("SmallCap"). No unquoted investments are permitted. Investment Policy The Company looks to achieve its objective and to diversify risk by investing in a portfolio of UK Smaller Companies. At the time of initial investment, a potential investee company must be profitable and smaller than the largest constituent of the HGSC Index, which represents the smallest 10% of the UK Stock Market by value. At the start of 2010, this was any company below £1.188 billion in size. The Manager looks to focus on the smaller end of this Index. In order to manage risk the Manager will normally limit any one holding to a maximum of 5% of the Company's investments. The weightings for every stock are closely monitored to ensure they reflect the underlying liquidity of the particular company. The Company's AIM exposure is also closely monitored by the Board and is limited to 30% of total investments with Board approval required for exposure to be above 25%. The Manager is focused on identifying high quality niche companies operating in growth markets. This typically leads the Manager to invest in companies that enjoy high barriers to entry, a sustainable competitive advantage and strong management teams. The portfolio is therefore constructed on a "bottom up" basis and there are no sectoral constraints placed on the Manager. The Board, in consultation with the Manager, is responsible for determining the gearing strategy for the Company. Gearing is used to enhance returns when the timing is considered appropriate. The Company currently has a credit facility of £15 million through ING Bank of which £10m is currently drawn down. The Board has agreed to limit borrowings to 25% of shareholders' funds. Benchmark FTSE SmallCap (excluding Investment Companies) Net Asset Value Performance 3 months 6 months 1 year 3 years 5 years Launch MUSCIT 3.4% 26.5% 42.6% (18.2%) 38.3% 187.7% Benchmark (8.2%) 23.1% 52.7% (39.3%) (15.3%) 37.3% Performance Summary (capital only) As at 31 As at 30 Movement December 2009 September 2009 Gross assets £105,963,954 £103,598,061 2.3% Net asset value 286.09p 277.67p 3.0% per share Share price 227.00p 226.00p 0.4% Discount 20.7% 18.6% Actual Gearing 10.4% 10.8% Net Gearing 9.5% 10.1% Period Review The third quarter of the Company's financial year to 31 December 2009 saw positive absolute and relative performance. This was a welcome relief after a previous challenging six months of underperformance. During this time, there was a sharp recovery in operationally and financially geared companies that are not compatible with the Manager's quality investment style. The FTSE SmallCap Index fell 8% in the fourth quarter of 2009 and underperformed large stocks for the first time this year. Despite a rather dull final three months, 2009 was a stellar year for SmallCap. From the period from 9 March to 19 October our benchmark the FTSE SmallCap Index returned 93%, delivering outperformance of a remarkable 44% against the FTSE 100 Index. After such a dramatic move, a period of consolidation was to be expected. Despite this, positive returns could still be obtained from good stock selection. The portfolio's NAV rose by 3% over the quarter, an outperformance of 12%. The Company benefited from the shift in the market's style bias away from recovery stocks in favour of quality growth. This market environment is one to which the house style is more suited. The Company's strongest performers over the fourth quarter of 2009 were some of the portfolio's smaller companies, with the six most material contributors to performance all being listed on either AIM or the FTSE Fledgling Index. Carclo (Chemicals; £90m market cap) and Dialight (Electronics; £80m market cap) both benefited from an increased awareness of the value that LEDs will have both as energy efficient and cost saving devices. Immunodiagnostics (Health; £190m market cap), which was up almost 75% in the final three months, continued to benefit from the value being placed by physicians on testing for Vitamin D and consequently the company's diagnostic tests were in demand. While top line growth will be hard to achieve in 2010 it can be found. There will always be companies that succeed in under promising and over delivering on earnings forecasts. As these businesses report 2009 results over the coming months, we expect to see evidence that they have benefited from a combination of improved competitive positions, weaker Sterling and cost-cutting. This should leave them with every prospect of recording earnings upgrades and continued good absolute returns for investors. In an environment that should reward strong stock-picking, the Company continues to have £10m drawn down from its facility with ING representing gearing of 10% at the end of 2009. This is in marked contrast to a year ago when we were un-geared. Material Events The Board has announced that following many years of service, Mr Christopher Jones will not be seeking re-election at the Company's 2010 AGM. Following Mr Jones's retirement Mr Laurence Petar will be appointed the Senior Independent Director. The Board has further announced its intention to appoint Miss Kathryn Matthews as a non executive director with effect from 1 April 2010. The Board is pleased to report that with effect from February 1st 2010 Charles Montanaro resumed his role as the Portfolio Manager (at Montanaro Asset Management) responsible for managing the Montanaro UK Smaller Companies Investment Trust. Charles Montanaro was the Portfolio Manager from inception of the Trust in 1995 until 2006. Charles is the Founder, CEO and CIO of Montanaro Asset Management which today has a total staff of 23. The Board would like to thank Dan Harlow for his involvement over the last 3 years and wish him well for the future. Top Ten Holdings as at 31 December 2009 Company Sector % of total portfolio Hargreaves Services Support Services 2.7 Dignity General Retailers 2.5 Fisher (J) & Sons Industrial Transportation 2.5 eaga Support Services 2.4 Carclo Chemicals 2.4 Hill & Smith Industrial Engineering 2.4 Latchways Support Services 2.2 James Halstead Construction & Materials 2.2 Dechra Pharmaceuticals Pharmaceuticals & Biotechnology 2.2 Ricardo Support Services 2.1 23.6 Sector Breakdown Sector % of total % of market portfolio Aerospace & Defense 3.3 2.3 Beverages 1.8 0.0 Chemicals 5.4 2.0 Construction & Materials 3.4 4.8 Electronic & Electrical 7.4 1.5 Equipment Food & Drug Retailers 1.4 0.3 Food Producers 2.8 2.8 General Financial 6.0 5.5 General Retailers 6.4 6.6 Health Care Equipment & 5.9 3.4 Services Household Goods 0.0 1.4 Industrial Engineering 4.0 3.4 Industrial Transportation 4.8 4.1 Leisure Goods 0.0 1.5 Life & Nonlife Insurance 0.0 4.4 Media 1.4 5.2 Mining 0.0 2.0 Oil & Gas Producers 2.8 1.6 Other 0.0 3.2 Pharmaceuticals & 3.0 4.1 Biotechnology Real Estate 7.3 15.1 Software & Computer Services 7.5 6.8 Support Services 20.6 12.1 Technology Hardware & 0.0 1.5 Equipment Travel & Leisure 4.8 4.4 100.0 100.0 This Interim Management Statement and up to date NAV and Share Price are available at the Company's website www.montanarouksmaller.co.uk.
UK 100

Latest directors dealings